Member   |  中文 | English

Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.

Service Hotline:

+86 29 82681864 

Online customer service
Service Hotline:
+86 29 82681864
Customer service team:
Online Service:
Service time:
8:00 - 24:00

Tel: +86 29 82681864   +86 15002902555 Fax: +86 29 82681864

E-mail: gd_hipec@126.com

Add: Building 1, Huoju Road, East zone of Xi’an High-tech Development District, Xi'an, China

WeChat

Mobile

Professional 

Clinical Internal Medicine

Page view

Body entrance

Puncture --One way perfusion

Treatment of diffuse metastases in thoracic

and abdominal cavity

 

 

Based on the principle of tumor hyperthermia, using the external electromagnetic induction heating device of hyperthermic perfusion chemotherapy system, the treatment solution is continuously heated to the treatment temperature, introduced into the patient's body cavity through the power circulation pump, and the effective treatment temperature is maintained within 60 minutes to give full play to the thermal killing mechanism.Process thermal cleaning of metastatic cancer cells widely cultivated in serous, and add chemotherapy drugs with heat sensitization effect according to the characteristics such as metabolic block of cancer cells and damage of genetic material after HIPEC, to force cancer cells to stop dividing, eliminate lesions that causes malignant effusion , make rapid repair of the biofilm, and achieve the goal of effective treatments for cancer effusion.

 

Start

B ultrasound

positioning

 

Keep appropriate amount of circulating fluid until

the end of treatment

The end of treatment

Adjuvant therapy for prevention and treatment of implant metastasis of malignant tumors such as lung cancer, gastric cancer, intestinal cancer, ovarian cancer and pancreatic cancer during and after operation

Postoperative treatment of unresectable cancer cells, metastatic nodules, enlarged lymph nodes and residual

small lesions

Malignant coelomic effusion (pleural, abdominal)

 

Treatment of malignant pleuroperitoneal mesothelioma

 

Cardiovascular insufficiency

Body temperature above 38 degree C

 

Bleeding-prone diseases

 

Severe thoracic and abdominal adhesions

Poor patient compliance

Body exit

Puncture or catheterization -- replacement of effusion and then into circulation mode -- preset temperature -- chemotherapy drugs will be added when the body entrance temperature reaches the treatment temperature -- maintain circulatory perfusion for 60 minutes at constant temperature

 

Obvious

curative effect

 

No damage to physiological function and no adverse sequelae

 

 
 

Reduce the toxic and side effects of chemotherapy drugs in body

cavity

 

Lung adenocarcinoma hydrothorax:After one time pleural hyperthermic perfusion,hydrothorax can only be detected to scatter in masses of cancer cells.Most of the cancer cells have been degraded by apoptosis.

Pathological Picture

 

 
 

Tumor tissue biopsy:a cluster of cancer cells with variable size and morphology and darker staining before treatment.After thermal perfusion,the cancer cells disappeared.

 

1

Short treatment course

 

3 times of average treatment and 10 days

of average hospitalization

 

 

The control effective rate of cancerous effusion is significantly improved

2

Stable long-term effect

 

New means

 

The remission period is prolonged,the quality of life is significantly improved,and the recurrence rate is reduced

3

 
 

—— Clinical application of thermostatic circulatory hyperthermia perfusion chemotherapy in the prevention and treatment of body cavity metastatic cancer

 

4

Toxic side

effects

 

5

6

Good method for prevention and treatment of cancerous implantation metastasis and prevention of malignant peritoneal effusion

 

 
 

Clinical indications

Contraindication

 
 
 

Clinical Indications

 
 

A. Adjuvant treatment for the prevention and treatment of implantation metastatic cancer during and after the operation of celomic malignancies such as lung cancer, gastric cancer, colorectal cancer, ovarian cancer and pancreatic cancer

B. Postoperative treatment of cancer cells, metastatic nodules, enlarged lymph nodes and residual small lesions that cannot be removed by surgery

C. Malignant body cavity effusion (pleural cavity, peritoneal cavity)

D. Treatment of pleuroperitoneal cavity diffuse metastatic tumor

E. Treatment of malignant pleuroperitoneal mesothelioma

 

Treatment Principle

 

 
 
 
 
 
 

Changes of hydrocele before and after one-time intracavitary

circulatory thermal perfusion

 

 

Graphical Description 

 

 
 
 

Ideal Practical Value Six Advantages

 

Sequela

 

Yellow

Bloody

Chylous

Jelly like

Excreted fibrous tissue

Excreted neoplasm nodules